Pierre Fabre and EORTC open a large Phase III clinical study i... - 25 May 2022 16:15

CASTRES, France and BRUSSELS, May 24, 2022 /PRNewswire-AsiaNet/ -- - First study conducted in the adjuvant setting with a combination of BRAF and MEK inhibitors in high-risk stage II BRAF V600E/K-mutant cutaneous melanoma - A global partnership between EORTC and Pierre Fabre to advance research in melanoma ...

  Insilico Medicine Announces Novel 3CL Protease Inhibitor Precl... - 25 May 2022 07:00

NEW YORK, May 25, 2022 /PRNewswire-AsiaNet/ -- -Insilico's candidate demonstrated a favorable profile with good in vivo efficacy at low doses, efficient synthesis, and no need for co-administration with Ritonavir. -The candidate is intended to be used for the treatment of SARS-CoV-2 and its v...

  UAE powerhouse VPS Healthcare launches Burjeel Holdings to sca... - 24 May 2022 23:08

DAVOS, Switzerland, May 24, 2022 /PRNewswire-AsiaNet/ - On the sidelines of the World Economic Forum Annual Meeting, the UAE-based private healthcare services platform commits 50 pediatric stem cell transplantations to refugees of the Ukraine conflict The UAE-based VPS Healthcare has announc...

  Fullerton Health Chronicles COVID-19 Journey in E-book - 24 May 2022 20:03

SINGAPORE, May 24, 2022 /PRNewswire-AsiaNet/ -- Fullerton Health has today released 'The Mighty Storm - Fullerton Health Rises to the Challenge', a 68-page e-book that chronicles Fullerton Health's struggles, challenges and successes in support of the nation's two-year fight against the pandemi...

  OptraSCAN's Artificial Intelligence-Equipped Digital Pathology... - 24 May 2022 09:00

SAN JOSE, Calif., May 24, 2022 /PRNewswire-AsiaNet/ -- OptraSCAN(R) [https://www.optrascan.com/], the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent - No 2020/0334814 A1 by the United States Patent and Trademark Off...

  Medison Pharma Announces Extension of Multi-territorial Agreem... - 23 May 2022 22:04

PETACH TIKVAH, Israel, May 23, 2022 /PRNewswire-AsiaNet/ -- Medison Pharma [https://www.medisonpharma.com/] ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, today announced the addition of new markets to its multi-territor...

  Karyopharm and Menarini Group Receive Positive CHMP Opinion fo... - 21 May 2022 01:15

NEWTON, Mass. and FLORENCE, Italy, May 20, 2022 /PRNewswire-AsiaNet/ -- -- European Commission Decision Anticipated within Approximately 60 Days -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group ("Menarini"), a private...

  Menarini Group and Radius Health, Inc. announce publication of... - 20 May 2022 19:07

FLORENCE, Italy and BOSTON, May 20, 2022 /PRNewswire-AsiaNet/ -- -Emerald study met both its primary end points of Progression-free survival (PFS) in overall population and in ESR1 mutated patients -PFS rate at 12 months with elacestrant was 22.32% vs. 9.42% with SOC in the overall population, and 26.76% vs. 8...

  Labaid Ltd. (Diagnostics) and Labaid Cancer Hospital & Super S... - 18 May 2022 14:29

DHAKA, Bangladesh, May 18, 2022 /PRNewswire-AsiaNet/ Labaid Ltd. (Diagnostics) and Labaid Cancer Hospital & Super Specialty Center, a part of the Labaid Group, have partnered with Darwinbox to achieve total digital transformation by 2026. This is in line with their vision of becoming Bangladesh'...

  Abl And Odimma Therapeutics Join Forces In Personalized Cancer... - 17 May 2022 18:00

PARIS, April 5, 2022 /PRNewswire-AsiaNet/ -- ABL Europe (ABL) [https://www.abl-biomanufacturing.com/ ], a pure play contract development and manufacturing organization (CDMO) specialized in development and manufacturing of virus for vaccine candidates, gene and cancer therapies and Odimma Th...